Infectious serology and atherosclerosis: How burdensome is the risk?

Circulation

Volumn 107, Issue 2, 2003, Pages 220-222

  Muhlestein, Joseph B ^a,b   Anderson, Jeffrey L ^a  

^a UNIVERSITY OF UTAH   (United States)

^b LDS HOSPITAL   (United States)

Author keywords

Atherosclerosis; Editorials; Risk factors

Indexed keywords

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CYTOMEGALOVIRUS; EDITORIAL; HELICOBACTER PYLORI; HERPES VIRUS; HUMAN; MEDICAL RESEARCH; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR;

ARTERIOSCLEROSIS; CAUSALITY; CHLAMYDOPHILA INFECTIONS; COMORBIDITY; DNA VIRUS INFECTIONS; HELICOBACTER INFECTIONS; HEPATITIS A; HUMANS; INFLAMMATION; RISK ASSESSMENT; RISK FACTORS; RNA VIRUS INFECTIONS; SEROEPIDEMIOLOGIC STUDIES;

EID: 0037458061     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000043909.78380.A0     Document Type: Editorial

References (20)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-126.
2. Epstein SE, Zhou YF, Zhu J. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation. 1999;100:e20-e28.
3. Anderson JL, Muhlestein JB. Pathophysiology: infection. In: Theroux P, Braunwald E, eds. Acute Coronary Syndromes: A Companion to Braunwald's Textbook of Cardiovascular Medicine. Philadelphia, Pa: WB Saunders. In press.
4. Zebrack JS AJ. The role of inflammation and infection in the pathogenesis and evolution of coronary artery disease. Curr Cardiol Rep. 2002;4:278-288.
5. Muhlestein JB, Anderson JL, Hammond EH, et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation. 1998;97:633-636.
6. Muhlestein JB, Hammond EH, Carlquist JF, et al. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol. 1996;27:1555-1561.
7. Prasad A, Zhu J, Halcox JPJ, et al. Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation 2002;106:184-190.
8. Zhou YF, Shou M, Guetta E, et al. Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall. Circulation. 1999;100:1569-1575.
9. Danesh J, Whincup P, Walker M, et al. Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ. 2000;321:208-213.
10. Danesh J. Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae, and cytomegalovirus: meta-analyses of prospective studies. Am Heart J. 1999;138:S434-S437.
11. Ridker PM, Danesh J, Youngman L, et al. A prospective study of Helicobacter pylori seropositivity and the risk for future myocardial infarction among socioeconomically similar U. S. men. Ann Intern Med. 2001;135:184-188.
12. Anderson JL, Carlquist JF, Muhlestein JB, et al. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol. 1998;32:35-41.
13. Nieto FJ. Viruses and atherosclerosis: a critical review of the epidemiologic evidence. Am Heart J. 1999;138:S453-S460.
14. Muhlestein JB, Home BD, Carlquist JF, et al. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation. 2000;102:1917-1923.
15. Blankenberg S, Rupprecht HJ, Bickel C, et al. Cytomegalovirus infection with interleukin-6 response predicts cardiac mortality in patients with coronary artery disease. Circulation. 2001;103:2915-2921.
16. Zhu J, Quyyumi AA, Norman JE, et al. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol. 2000;85:140-146.
17. Zhu J, Nieto FJ, Home BD, et al. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation. 2001;103:45-51.
18. Rupprecht HJ, Blankenberg S, Bickel C, et al. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation. 2001;104:25-31.
19. Smieja M, Gnarpe J, Lonn E, et al. Multiple infections, subsequent cardiovascular events, and atherosclerotic progression in the Heart Outcome and Prevention Evaluation (HOPE) Study. Circulation. 2003;107:251-257.
20. Kiechl S, Egger G, Mayr M, et al. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation. 2001;103:1064-70.